PET/CT in restaging, prognosis, and recurrence in patients with malignant melanoma
Abstract Background Cutaneous malignant melanoma (CMM) is a highly aggressive tumor with high tendency of return despite complete surgical removal. It has a high risk of dissemination to regional lymph nodes and visceral organs. The prognosis is highly dependent on lymph node involvement and distant...
Main Authors: | Kholoud H. El-Shourbagy, Emad M. Mashaly, Sameh A. Khodair, Mohamed M. Houseni, Rania S. Abou Khadrah |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-08-01
|
Series: | The Egyptian Journal of Radiology and Nuclear Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43055-020-00276-1 |
Similar Items
-
Giant adrenal metastasis of malignant melanoma: impact of 18F-FDG PET/CT in early assessment of dramatic response to immunotherapy: case report
by: Forough Kalantari, et al.
Published: (2023-09-01) -
TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma
by: Ylva Naeser, et al.
Published: (2020-12-01) -
Schwannomas mistaken for metastases of melanoma in PET‐CT: A diagnostic challenge with consequences
by: Stefanie Hirsiger, et al.
Published: (2022-12-01) -
Omental deposits surveillance in gynecological malignancies at first setting follow up: 18F-FDG PET/CT compared to CT
by: Tamer W. Kassem
Published: (2017-06-01) -
Brain Metastases Unresponsive to Immunotherapy Detected by 18F-FDG-PET/CT in a Patient with Melanoma
by: Rosa Fonti, et al.
Published: (2020-06-01)